Legence Sees Q2 Sales $1.050B-$1.100B vs $913.658M Est

Benzinga Newsdesk www.benzinga.com Positive 85.0%

Neg 0% Neu 0% Pos 85%

Legence (NASDAQ:LGN) sees Q2 sales of $1.050 billion-$1.100 billion vs $913.658 million analyst estimate.

Comments

No comments yet. Be the first!